Renal cortical regulation of COX-1 and functionally related products in early renovascular hypertension (rat)

American Journal of Physiology - Renal Physiology

Volumn 291, Issue 5, 2006, Pages

  Theilig, F ^a   Debiec, H ^b   Nafz, B ^a   Ronco, P ^b   Nusing R ^c   Seyberth, H W ^c   Pavenstadt H ^d   Bouby, N ^b   Bachmann, S ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b INSERM   (France)

^c Zentrum für Kinder und Jugendmedizin   (Germany)

^d Medizinische Poliklinik   (Germany)

Author keywords

Bradykinin; Cyclooxygenase; Nitric oxide synthase

Indexed keywords

ANGIOTENSIN II; BRADYKININ B2 RECEPTOR; CANDESARTAN; CYCLIC GMP; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; MICROTUBULE ASSOCIATED PROTEIN 1; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN SYNTHASE; PROSTANOID; ANGIOTENSIN RECEPTOR ANTAGONIST; BENZIMIDAZOLE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRADYKININ; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DRUG DERIVATIVE; ICATIBANT; MEMBRANE PROTEIN; NITRIC OXIDE; NOS1 PROTEIN, RAT; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN EP3 RECEPTOR; PROSTANOID RECEPTOR EP1; PTGS1 PROTEIN, RAT; PTGS2 PROTEIN, RAT; TETRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN URINE LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RENOVASCULAR HYPERTENSION; ANIMAL; BLOOD PRESSURE; DISEASE MODEL; ENZYMOLOGY; GENETICS; HENLE LOOP; KIDNEY COLLECTING TUBULE; KIDNEY CORTEX; KIDNEY DISTAL TUBULE; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; SURGICAL INSTRUMENT; URINE;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BENZIMIDAZOLES; BLOOD PRESSURE; BRADYKININ; CYCLIC GMP; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DINOPROSTONE; DISEASE MODELS, ANIMAL; HYPERTENSION, RENOVASCULAR; KIDNEY CORTEX; KIDNEY TUBULES, COLLECTING; KIDNEY TUBULES, DISTAL; LOOP OF HENLE; MALE; MEMBRANE PROTEINS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PROSTAGLANDIN E; SURGICAL INSTRUMENTS; TETRAZOLES;

EID: 33750960706     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00099.2006     Document Type: Article

References (42)

1. Bachmann S, Mutig K, Bates J, Welker P, Gross V, Luft FC, Alenina N, Bader M, Thiele BJ, Prasadan K, Raffi HS, and Kumar S. Renal effects of Tamm Horsfall protein (uromodulin) deficiency in mice. Am J Physiol Renal Physiol 288: F559-F567, 2005.
2. Bonvalet JP, Pradelles P, and Farman N. Segmental synthesis and actions of prostaglandins along the nephron. Am J Physiol Renal Fluid Electrolyte Physiol 253: F377-F387, 1987.
3. Bosse HM, Böhm R, Resch S, and Bachmann S. Parallel regulation of constitutive NO synthase and renin at the juxtaglomerular apparatus of rat kidney under various stimuli. Am J Physiol Renal Fluid Electrolyte Physiol 269: F793-F805, 1995.
4. Breyer MD and Breyer RM. G protein-coupled prostanoid receptors and the kidney. Annu Rev Physiol 63: 579-605, 2001.
5. Câmpean V, Theilig F, Paliege A, Breyer M, and Bachmann S. Key enzymes for renal prostaglandin synthesis: site-specific expression in rodent kidney (rat, mouse). Am J Physiol Renal Physiol 285: F19-F32, 2003.
6. Castrop H, Vitzthum H, Schumacher K, Schweda F, and Kurtz A. Low tonicity mediates a downregulation of cyclooxygenase-1 expression by furosemide in the rat renal papilla. J Am Soc Nephrol 13: 1136-1144, 2002.
7. 2 receptor in mice worsens two-kidney, one-clip hypertension: role of NO and the AT2 receptor. J Hypertens 21: 1531-1538, 2003.
8. Cheng HF, Wang JL, Zhang MZ, McKanna JA, and Harris RC. Role of p38 in the regulation of renal cortical cyclooxygenase-2 expression by extracellular chloride. J Clin Invest 106: 681-688, 2000.
9. Cheng HF and Harris RC. Cyclooxygenases, the kidney, and hypertension. Hypertension 43: 525-530, 2004.
10. Cheng HF, Zhang MZ, and Harris RC. Nitric oxide stimulates cyclooxygenase-2 in cultured cTAL cells through a p38-dependent pathway. Am J Physiol Renal Physiol 290: F1391-F1397, 2006.
11. Emond C, Bascands JL, Rakotoarivony J, Praddaude F, Bompart G, Pecher C, Ader JL, and Girolami JP. Glomerular B2-kinin-binding sites in two-kidney, one-clip hypertensive rats. Am J Physiol Renal Fluid Electrolyte Physiol 260: F626-F634, 1991.
12. 2 receptor in rat kidney by anti-peptide and anti-ligand antibodies. J Histochem Cytochem 43: 137-148, 1995.
13. Freeman RH, Davis JO, Williams GM, and Seymour AA. Circadian changes in plasma renin activity and plasma aldosterone concentration in one-kidney hypertensive rats. Proc Soc Exp Biol Med 169: 86-89, 1982.
14. Garovic VD and Textor SC. Renovascular hypertension and ischemic nephropathy. Circulation 112: 1362-1374, 2005.
15. + absorption by activating the EP1 receptor. J Clin Invest 102: 194-201, 1998.
16. Hartner A, Cordasic N, Goppelt-Struebe M, Veelken R, and Hilgers KF. Role of macula densa cyclooxygenase-2 in renovascular hypertension. Am J Physiol Renal Physiol 284: F498-F502, 2003.
17. 2 inhibits sodium transport in rabbit cortical collecting duct by increasing intracellular calcium. J Clin Invest 87: 1992-1998, 1991.
18. Höcherl K, Wolf K, Castrop H, Ittner KP, Bucher M, Kees F, Grobecker HF, and Kurtz A. Renocortical expression of renin and of cyclooxygenase-2 in response to angiotensin II AT1 receptor blockade is closely coordinated but not causally linked. Pflügers Arch 442: 821-827, 2001.
19. Ichihara A, Imig JD, Inscho EW, and Navar LG. Cyclooxygenase-2 participates in tubular flow-dependent afferent arteriolar tone: interaction with neuronal NOS. Am J Physiol Renal Physiol 275: F605-F612, 1998.
20. 2 ratios in unilateral renovascular hypertension of different severities. Hypertension 38: 23-29, 2001.
21. Imig JD, Zhao X, Orengo SR, Dipp S, and El-Dahr SS. The bradykinin B2 receptor is required for full expression of renal COX-2 and renin. Peptides 24: 1141-1147, 2003.
22. Jakobsson PJ, Thoren S, Morgenstern R, and Samuelsson B. Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc Natl Acad Sci USA 96: 7220-7225, 1999.
23. Kotnik P, Nielsen J, Kwon TH, Krzisnik C, Frokiaer J, and Nielsen S. Altered expression of COX-1, COX-2, and mPGES in rats with nephrogenic and central diabetes insipidus. Am J Physiol Renal Physiol 288: F1053-F1068, 2005.
24. + conductance in the rat cortical collecting duct. J Gen Physiol 110: 717-726, 1997.
25. 2-receptor knockout mice. Hypertension 32: 503-509, 1998.
26. Mann B, Hartner A, Jensen BL, Kammerl M, Kramer BK, and Kurtz A. Furosemide stimulates macula densa cyclooxygenase-2 expression in rats. Kidney Int 59: 62-68, 2001.
27. Morath R, Klein T, Seyberth HW, and Nüsing RM. Immunolocalization of the four prostaglandin E2 receptor proteins EP1, EP2, EP3, and EP4 in human kidney. J Am Soc Nephrol 10: 1851-1860, 1999.
28. Moreau ME, Garbacki N, Molinaro G, Brown NJ, Marceau F, and Adam A. The kallikrein-kinin system: current and future pharmacological targets. J Pharm Sci 99: 6-38, 2005.
29. 1 receptor blockade. J Am Soc Nephrol 10, Suppl 12: S266-S272, 1999.
30. Navar LG and Harrison-Bernard LM. Intrarenal angiotensin II augmentation in angiotensin II dependent hypertension. Hypertens Res 23: 291-301, 2000.
31. 2. Am J Physiol Renal Physiol 287: F152-F159, 2004.
32. Paliege A, Parsumathy A, Mizel D, Yang T, Schnermann J, and Bachmann S. Effect of apocynin treatment on renal expression of COX-2, NOS1, and renin in Wistar-Kyoto and spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 290: R694-R700, 2006.
33. 2 release from macula densa cells. J Clin Invest 112: 76-82, 2003.
34. Qi Z, Hao CM, Langenbach RI, Breyer RM, Redha R, Morrow JD, and Breyer MD. Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II. J Clin Invest 110: 61-69, 2002.
35. Schneider A, Zhang Y, Zhang M, Lu WJ, Rao R, Fan X, Redha R, Davis L, Breyer RM, Harris R, Guan Y, and Breyer MD. Membrane-associated PGE synthase-1 (mPGES-1) is coexpressed with both COX-1 and COX-2 in the kidney. Kidney Int 65: 1205-1213, 2004.
36. Schnermann J. Cyclooxygenase-2 and macula densa control of renin secretion. Nephrol Dial Transplant 16: 1735-1738, 2001.
37. Schricker K, Hamann M, and Kurtz A. Prostaglandins are involved in the stimulation of renin gene expression in 2 kidney-1 clip rats. Pflügers Arch 430: 188-194, 1995.
38. Schweer H, Watzer B, Seyberth HW, and Nüsing RM. Improved quantification of 8-epi-prostaglandin F2 alpha and F2-isoprostanes by gas chromatography/triple-stage quadrupole mass spectrometry: partial cyclooxygenase-dependent formation of 8-epi-prostaglandin F2 alpha in humans. J Mass Sprectrom 32: 1362-1370, 1997.
39. Theilig F, Bostanjoglo M, Pavenstädt H, Grupp C, Holland G, Slosarek I, Gressner AM, Russwurm M, Koesling D, and Bachmann S. Cellular distribution and function of soluble guanylyl cyclase in rat kidney and liver. J Am Soc Nephrol 12: 2209-2220, 2001.
40. Theilig F, Câmpean V, Paliege A, Breyer M, Briggs JP, Schnermann J, and Bachmann S. Epithelial COX-2 expression is not regulated by NO: colocalization studies in rat and mouse renal cortex. Hypertension 39: 848-853, 2002.
41. Wang JL, Cheng HF, and Harris RC. Cyclooxygenase-2 inhibition decreases renin content and lowers blood pressure in a model of renovascular hypertension. Hypertension 34: 96-101, 1999.
42. Ye W, Zhang H, Hillas E, Kohan DE, Miller RL, Nelson RD, Honeggar M, and Yang T. Expression and function of COX isoforms in renal medulla: evidence for regulation of salt sensitivity and blood pressure. Am J Physiol Renal Physiol 290: F542-F549, 2006.